| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Science | 2011 | 3.8K |
| Natural innate and adaptive immunity to cancer | Annual Review of Immunology | 2011 | 1.4K |
| Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors | Cancer Research | 2011 | 396 |
| Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy | Proceedings of the National Academy of Sciences of the United States of America | 2011 | 334 |
| Activating and inhibitory receptors of natural killer cells | Immunology and Cell Biology | 2011 | 332 |
| CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis | Cancer Research | 2011 | 297 |
| Presumed guilty: natural killer T cell defects and human disease | Nature Reviews Immunology | 2011 | 272 |
| Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy | Journal of Experimental Medicine | 2011 | 261 |
| Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors | Cancer Research | 2011 | 239 |
| DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice | Journal of Experimental Medicine | 2011 | 140 |
| Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria | Journal of Immunology | 2011 | 132 |
| The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy | Blood | 2011 | 129 |
| Autoimmunity associated with immunotherapy of cancer | Blood | 2011 | 128 |
| A role for Blimp1 in the transcriptional network controlling natural killer cell maturation | Blood | 2011 | 118 |
| Improving cancer immunotherapy by targeting tumor-induced immune suppression | Cancer and Metastasis Reviews | 2011 | 115 |
| Prospects for TIM3-Targeted Antitumor Immunotherapy | Cancer Research | 2011 | 99 |
| Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies | Proceedings of the National Academy of Sciences of the United States of America | 2011 | 88 |
| A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma | Blood | 2011 | 69 |
| IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice | Journal of Leukocyte Biology | 2011 | 65 |
| The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome | Journal of Leukocyte Biology | 2011 | 65 |
| Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice | Cancer Immunology, Immunotherapy | 2011 | 55 |
| Protection from endogenous perforin: glycans and the C terminus regulate exocytic trafficking in cytotoxic lymphocytes | Immunity | 2011 | 54 |
| Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer | Immunotherapy | 2011 | 39 |
| Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases | Cancer Research | 2011 | 38 |
| Biology and clinical observations of regulatory T cells in cancer immunology | Current Topics in Microbiology and Immunology | 2011 | 27 |
